Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;11(12):1430-1438.
doi: 10.1016/j.jalz.2015.04.006. Epub 2015 Jun 13.

Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease

Liv Tybjærg Nordestgaard  1 , Anne Tybjærg-Hansen  2 , Børge G Nordestgaard  3 , Ruth Frikke-Schmidt  4
Affiliations

Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease

Liv Tybjærg Nordestgaard et al. Alzheimers Dement. 2015 Dec.

Abstract

Introduction: The adenosine triphosphate-binding cassette transporter A1 (ABCA1) is a major cholesterol transporter highly expressed in the liver and brain. In the brain, ABCA1 lipidates apolipoprotein E (apoE), facilitates clearance of amyloid-β, and may be involved in maintenance of the blood-brain barrier via apoE-mediated pathways.

Methods: We tested whether a loss-of-function mutation in ABCA1, N1800H, is associated with plasma levels of apoE and with risk of Alzheimer's disease (AD) in 92,726 individuals and with risk of cerebrovascular disease in 64,181 individuals.

Results: N1800H AC (0.2%) versus AA (99.8%) was associated with a 13% lower plasma level of apoE (P = 1 × 10(-11)). Multifactorially adjusted hazard ratios for N1800H AC versus AA were 4.13 (95% confidence interval, 1.32-12.9) for AD, 2.46 (1.10-5.50) for cerebrovascular disease, and 8.28 (2.03-33.7) for the hemorrhagic stroke subtype.

Discussion: A loss-of-function mutation in ABCA1, present in 1:500 individuals, was associated with low plasma levels of apoE and with high risk of AD and cerebrovascular disease in the general population.

Keywords: ATP-binding cassette transporter A1; Alzheimer's disease; Apolipoprotein E; Blood-brain barrier; Cerebrovascular disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

Substances